Patent details

Basic Information

Publication number:

EP1200116

PCT Application Number:

PCT/DK/2000/000401

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP009437062

PCT Publication Number:

WO/2001/005353

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF FVIIa OR A TISSUE FACTOR AGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS

French Title of Invention:

UTILISATION DE FVIIa OU D'UN AGONISTE DE FACTEUR TISSULAIRE TF POUR REGULER L'EXPRESSION GENIQUE, ET MIGRATION CELLULAIRE OU CHIMIOTAXIE

German Title of Invention:

VERWENDUNG VON FVIIa ODER EINES GEWEBEFAKTORAGONISTEN ZUR REGULIERUNG DER GENEXPRESSION UND ZELLMIGRATION ODER CHEMOTAXIS

SPC Number:

Dates

Filing date:

14/07/2000

Grant date:

15/10/2008

EP Publication Date:

15/10/2008

PCT Publication Date:

25/01/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/05/2002

EP B1 Publication Date:

15/10/2008

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/07/2009

Expiration date:

14/07/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/07/2000

 

 

Name:

Novo Nordisk Health Care AG

Address:

Andreasstrasse 15, 8050 Zürich, Switzerland (CH)

Inventor

1

Name:

SIEGBAHN Agneta

Address:

Sweden (SE)

2

Name:

PETERSEN Lars, Christian

Address:

Denmark (DK)

3

Name:

EZBAN Mirella

Address:

Denmark (DK)

Priority

1

Priority Number:

102399

Priority Date:

14/07/1999

Priority Country:

Denmark (DK)

2

Priority Number:

111799

Priority Date:

12/08/1999

Priority Country:

Denmark (DK)

Classification

Main IPC Class:

A61K 38/36;

Filing date	Document type	Number of pages